Form 4 for INVA Innoviva, Inc.

Accepted 2022-03-02 00:00:00 ET · period of report 2022-03-01 · accession 0001567619-22-006130 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-03-02	2022-03-01	INVA	Zhen Marianne	CAO	A - Grant	$0.00	+6,691	38.9K	+21%	$0
D	2022-03-02	2022-03-01	INVA	Zhen Marianne	CAO	A - Grant	$0.00	+15.0K	20.0K	+300%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-01	A	A	6,691	$0.00	38,872	D	—	—	(F1) The Reporting Person was granted a time-based restricted stock award ("RSA"). Twenty-five percent of the shares subject to the RSA shall vest on February 20, 2023, 6.25% on May 20, 2023, and an additional 6.25% on the final day of each 3-month period thereafter, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. The grant was approved by the Compensation Committee of the Board of Directors of the Company.
2	Derivative	Non-statutory Stock Option	2022-03-01	A	A	15,000	$0.00	20,000	D	$18.68 · 2023-02-20 to 2032-02-28	15,000 Common Stock	(F2) The Reporting Person was granted options. Twenty-five percent of the options shall vest on February 20, 2023, 6.25% on May 20, 2023, and an additional 6.25% on the final day of each 3-month period thereafter, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. The grant was approved by the Compensation Committee of the Board of Directors of the Company.